Eli Lilly CEO David Ricks comments on why it's cutting insulin prices now

France Nouvelles Nouvelles

Eli Lilly CEO David Ricks comments on why it's cutting insulin prices now
France Dernières Nouvelles,France Actualités
  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

NPR's Ailsa Chang talks with Eli Lilly CEO David Ricks about the company's move to reduce prices on some older insulins and cap how much people have to pay out of their own pocket.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NPRHealth /  🏆 144. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketEli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Lire la suite »

Drug Giant Eli Lilly Dramatically Slashes Price of InsulinDrug Giant Eli Lilly Dramatically Slashes Price of InsulinA hard-fought campaign to reduce the exorbitant price of insulin seems to finally be yielding some results.
Lire la suite »

'Brilliant PR Move': Advocates Skeptical as Eli Lilly Vows 70% Insulin Price Cut'Congress, not greedy corporations trying to redeem their tarnished reputations, should be leading the way on reforms that put patients ahead of pharmaceutical profits.'
Lire la suite »

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketEli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Lire la suite »

Drugmaker Eli Lilly Announces 70% Price Drop In Its 'Most Commonly Prescribed Insulins'Drugmaker Eli Lilly Announces 70% Price Drop In Its 'Most Commonly Prescribed Insulins'The announcement comes after waves of criticism from Americans saying the drug, which is vital to many people with diabetes, should be more accessible.
Lire la suite »



Render Time: 2025-03-10 12:54:54